Add like
Add dislike
Add to saved papers

Earlobe keloids: a pilot study of the efficacy of keloidectomy with core fillet flap and adjuvant intralesional corticosteroids.

BACKGROUND: Management of earlobe keloids is challenging because they are often resistant to treatment. The literature reports different treatment modalities with variable responses. Surgical excision with core fillet flap in combination with adjuvant intralesional steroid injection has not been thoroughly explored for keloid treatment, in spite of its positive therapeutic and cosmetic outcome.

OBJECTIVES: To evaluate the clinical efficacy of keloidectomy with core fillet flap and adjuvant intralesional steroid injection in treating earlobe keloids.

MATERIALS AND METHODS: Between 2004 and 2012, 21 earlobe keloids were treated using keloidectomy with core fillet flap and given intraoperative intralesional steroid injections. Follow-up was scheduled 2 weeks after the procedure and then monthly to administer intralesional steroid injections and to assess response, postoperative complications, recurrence, and objective and subjective satisfaction.

RESULTS: The clinical outcome efficacy was 87.6%. Mean follow-up was 21.9 months. Immediate recurrence was 9.5%, with few complications encountered. Subjectively, 82.3% of the patients were highly satisfied.

CONCLUSION: Keloidectomy with core fillet flap and adjuvant intralesional steroid therapy is an effective modality for the clinical management of earlobe keloids. This approach should be considered for the treatment of this difficult condition.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app